TTNP's logo.
Ticker Symbol: TTNP

Titan Pharmaceuticals, Inc. (de)

$1.57 - 20-11-2024 4 p.m. ET

Exchange: NASDAQ Country: US Currency: USD Asset Type: Common Stock CIK:0000910267

Company Profile

Titan Pharmaceuticals, Inc., based in South San Francisco, CA, is a development stage company developing proprietary therapeutics with its ProNeura® long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: 400 Oyster Point Blvd Ste 505
CEO: N/A
Tags:
  • Health Technology
  • Biotechnology
  • Pharmaceuticals: Major
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

Pricing

Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.45
Change: $0.00 ( -0.70%)
Days Range: $0.43 - $0.47
Beta: 0.06
52wk. High: $1.13
52wk. Low: $0.36
Ytd. Change -42.21%
50 Day Moving Average: $0.46
200 Day Moving Average: $0.62
Shares Outstanding: 15016295

Valuation

Market Cap: 682.9M
PE Ratio: -0.80
EPS (TTM): -0.5705

Dividends

Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A